𝔖 Bobbio Scriptorium

✦ LIBER ✦

Poster 63: Utility of Treatment Implementation Methods in a Clinical Trial With Rehabilitation Teams

✍ Scribed by Alan B. Stevens; Dale Strasser; Jay Uomoto; Susan Bowen; Judith Falconer

Book ID: 116236821
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 34 KB
Volume: 88
Category: Article
ISSN: 1532-821X
DOI: 10.1016/j.apmr.2007.08.097

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Poster 250 Utilization of subacute rehab

Poster 250 Utilization of subacute rehabilitation in the treatment of a closed head injury patient: Jeffrey E. Oken, MD (Marianjoy Rehabilitation Hospital and Clinics, Wheaton, IL); Lise P. Miller, BFA

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Poster #M189 THE EFFICACY OF OCCUPATIONA

Poster #M189 THE EFFICACY OF OCCUPATIONAL THERAPY IN THE REHABILITATION OF EXECUTIVE FUNCTIONS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA: A PILOT RANDOMIZED CONTROLLED TRIAL

✍ Vizzotto, Adriana Dias Barbosa.; Celestino, Diego Luis; Buchain, Patricia Cardos 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 89 KB

2110 POSTER Active specific immunotherap

2110 POSTER Active specific immunotherapy with NGcGM3/ VSSP/ Montanide ISA-51 (CIMAVaxG) vaccine in the treatment of patients with metastatic breast cancer: Results of a randomized phase II clinical trial

✍ A. Macias; A. Torres; A. Montenegro; P. Marinello; R. Rodriguez; V. Mulens; A. C 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

7512 POSTER Assessing the clinical impac

7512 POSTER Assessing the clinical impact of trabectedin in patients with leiomyosarcomas or liposarcomas (L-sarcomas) progressing despite prior conventional chemotherapy: clinical benefit rate, growth modulation index and tumor variation as parameters of treatment effect in a randomised international trial of two trabectedin dosing regimens

✍ Le Cesne, A.; von Mehren, M.; Chawla, S.; Blay, J.Y.; Schuetze, S.; Nieto, A.; G 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 82 KB

PRM90 Outcome Differences in Algorithms

PRM90 Outcome Differences in Algorithms Used for Indirect Mapping of Utility Values From HAQ-DI: An Assessment Based on Phase 2A Clinical Trial Data in Patients With Rheumatoid Arthritis After Treatment With NNC0109-0012 (Anti-II-20 MAB)

✍ Strandberg-Larsen, M.; Hansen, B.B.; Göthberg, M.; Valencia, X. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

53 POSTER A phase II, multicenter, rando

53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin®) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva®) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer

✍ R. Herbst; V. O'Neill; L. Fehrenbacher; C. Belani; P. Bonomi; L. Hart; O. Melnyk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB